Singular Health has moved closer to a proposed A$3.5 million Florida Medicaid imaging repository while deploying 1,000 physician licences through its largest customer network. The September quarter also exposed the execution risks ahead, with the Florida MOU still subject to definitive agreements and the PNS contract due for renewal by year-end.
- Proposed A$3.5 million share of Florida Medicaid repository project
- 1,000 3DICOM MD licences deployed across PNS network
- PNS renewal and expansion discussions continue ahead of 31 December deadline
- A$8.14 million cash, no debt and 4.25 quarters of funding
- A$0.47 million R&D tax incentive expected in the December quarter
Florida Repository Moves from MOU Towards Delivery
Singular Health Group Limited (ASX:SHG) has put a potential A$3.5 million project at the centre of its next growth phase: a secure medical imaging repository intended to support providers serving Florida Medicaid beneficiaries. The company’s proposed share is approximately US$2.55 million, funded within a US$3.0 million State of Florida appropriation to Florida International University.
The arrangement with FIU remains non-binding, although the parties are legally bound to enter definitive agreements based on the MOU’s minimum terms. That distinction matters: the proposed revenue is not yet secured, and the company’s funding calculations exclude any receipts from the repository.
The project’s final phase is designed as a clinical and economic validation pilot, testing whether shared access to earlier scans can reduce duplicate imaging and related costs in a defined Florida Medicaid population. Florida will own the underlying data, while Singular Health expects to use the resulting success metrics when approaching other health plans and state programs. The company previously outlined the project in its Florida Medicaid project MOU, which carried approximately A$3.5 million of potential revenue but remained dependent on definitive agreements and delivery.
PNS Deployment Reaches 1,000 Licences
Singular Health also reported that 1,000 3DICOM MD licences have now been deployed across Provider Network Solutions, its largest customer agreement. The licences are contracted at US$800 per physician per year, with the company focused during the quarter on utilisation and integration into clinical workflows.
That commercial relationship is now approaching a more immediate test. The PNS enterprise agreement is due for renewal by 31 December 2026, and discussions covering renewal, additional licences and broader network adoption remain under way. Earlier expansion talks had followed the PNS licence expansion, but the current filing does not say whether a renewed or expanded agreement has been reached.
Cash Runway Covers Just Over Four Quarters
Singular Health ended September with A$8.14 million in cash and no debt, down from A$10.07 million three months earlier. Net operating cash outflow was A$1.918 million for the quarter, while customer receipts were only A$10,000 because the US$800,000 PNS payment had been received in the previous financial year.
On that quarterly operating burn, the company reported approximately 4.25 quarters of available funding. A further A$0.47 million R&D tax incentive is expected in the December quarter, but the runway calculation does not include potential Florida Repository receipts. The quarter also included A$132,000 in related-party payments, comprising A$85,000 to the managing director, including a KPI bonus, and A$47,000 in non-executive director fees.
ImageIQ and US Platform Infrastructure Continue
Development and validation of ImageIQ continued across workflows for primary care, utilisation management and radiology benefit managers. The module is intended to help clinicians select an appropriate examination after 3DICOM Gateway identifies prior imaging, but it has not yet been commercially released and is planned as an add-on for networks already connected to 3DICOM.
The company retained certification following an MDSAP surveillance audit and progressed HITRUST preparations, while an independent architecture review continued to assess the platform’s ability to support larger healthcare networks. It also reported ongoing deployments with Life Radiology and Miami-Dade County Public Schools, alongside commercial discussions with US and Puerto Rico providers, health plans and strategic partners. Those opportunities remain at discussion or pilot stage.
December Quarter Has Two Commercial Tests
Singular Health’s immediate priorities are to execute definitive FIU agreements and begin repository delivery, secure the PNS renewal, and continue ImageIQ validation. An Australian patent covering the Medical File Transfer System underpinning its MFTP technology was granted on 1 October, shortly after the quarter ended.
The next update should therefore clarify two different questions: whether the Florida project can convert an attractive strategic proposition into contracted work, and whether PNS turns a 1,000-licence deployment into a renewed and potentially larger recurring relationship. Until then, the company has cash to pursue both, but not yet the contracted receipts to make either outcome certain.
Bottom Line?
The December quarter could convert Singular Health’s largest strategic claims into measurable commitments, with the FIU agreement and PNS renewal carrying more weight than the current licence count alone.
Questions in the middle?
- Will Singular Health and FIU execute definitive agreements for the Florida Repository, and on what delivery timetable?
- Can the PNS renewal preserve the existing 1,000-licence base while adding further network adoption?
- How much measurable reduction in duplicate imaging will the Florida pilot produce, and can that evidence support a savings-share model?